|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.927
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.912
|
|
|
|
multicellular organismal iron ion homeostasis
|
GO:0060586 |
8 |
0.757
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.732
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.702
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.699
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to iron
|
GO:0034395 |
3 |
0.676
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.657
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.656
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.655
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.618
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.554
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.518
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.465
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.377
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.372
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.345
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.323
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.317
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.316
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.297
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.293
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.288
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.280
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.278
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.270
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.267
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.265
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.264
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.255
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.253
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.244
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.242
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.239
|
|
|
|
iron ion import
|
GO:0097286 |
5 |
0.239
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.238
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.237
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.233
|
|
|
|
interleukin 17 production
|
GO:0032620 |
11 |
0.232
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.230
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.230
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.225
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.215
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.214
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.213
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.213
|
|
|
|
iron ion import into cell
|
GO:0097459 |
4 |
0.211
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.208
|
Mouse |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.204
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.203
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.200
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.200
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.199
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.197
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.195
|
|
|
|
iron ion transport
|
GO:0006826 |
17 |
0.194
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.189
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.183
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.176
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.175
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.174
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.171
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.169
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.168
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.166
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.165
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.164
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.160
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.160
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.153
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.147
|
|
|
|
antigen processing and presentation via mhc class ib
|
GO:0002475 |
8 |
0.144
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.144
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.144
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.139
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.137
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.137
|
|
|
|
copper ion transport
|
GO:0006825 |
10 |
0.134
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.132
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.129
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.128
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.127
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.125
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.123
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.123
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.123
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.123
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.121
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.118
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.117
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.114
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.112
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.111
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.110
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.110
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.110
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.109
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.108
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.107
|
Mouse |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.107
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.106
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.106
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.105
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.105
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.104
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.101
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.099
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.099
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.099
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.098
|
Mouse |
|
|
blood circulation
|
GO:0008015 |
195 |
0.097
|
Mouse |
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway
|
GO:0002484 |
3 |
0.097
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.096
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.096
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.094
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.094
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.094
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.091
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.091
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.090
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.089
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.088
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.088
|
Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.088
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.088
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.088
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.087
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.086
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.086
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.085
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.084
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.084
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.084
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.083
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.083
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.083
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.082
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.082
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.081
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.080
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.080
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.080
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.079
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.078
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.078
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.077
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.077
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.077
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.076
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.075
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.075
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.074
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.074
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.074
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.074
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.073
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.072
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.072
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.071
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.071
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.070
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.070
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.069
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.069
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.069
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.069
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.069
|
Mouse |
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.069
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.069
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.068
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.068
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.067
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.067
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.067
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.067
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.067
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.066
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.066
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.066
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.065
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.065
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.064
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.063
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.063
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.063
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.062
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.062
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.061
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.059
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.059
|
|
|
|
inorganic cation import into cell
|
GO:0098659 |
4 |
0.059
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
41 |
0.059
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.058
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.057
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.057
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.057
|
|
|
|
cellular zinc ion homeostasis
|
GO:0006882 |
9 |
0.056
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.056
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.055
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.055
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.055
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.055
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.054
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.054
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.053
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.053
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.053
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.053
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.052
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.052
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.052
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.052
|
|
|
|
cellular iron ion homeostasis
|
GO:0006879 |
16 |
0.051
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.051
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.051
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.051
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.050
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.050
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.050
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.050
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.049
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.048
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.048
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.048
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.048
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.048
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.048
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.047
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.047
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.047
|
|
|
|
positive regulation of macrophage activation
|
GO:0043032 |
10 |
0.047
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.046
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.046
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.046
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.046
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.046
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.046
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.046
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.046
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.045
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.045
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.044
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.044
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.044
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.044
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.044
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.044
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.044
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.043
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.043
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.043
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.043
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.042
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.042
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.041
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.041
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.041
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.041
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.041
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.041
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.041
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.040
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.040
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.040
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.039
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.039
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.039
|
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.039
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.039
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.039
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.038
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.038
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.038
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.038
|
|
|
|
stress response to metal ion
|
GO:0097501 |
3 |
0.038
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.038
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.038
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.038
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.038
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.038
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.037
|
|
|
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO:0045954 |
16 |
0.037
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.037
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.036
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.036
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.036
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.036
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.036
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.036
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.036
|
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib
|
GO:0002476 |
4 |
0.036
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.035
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.035
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.035
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.035
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.035
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.034
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.034
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.034
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.034
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.034
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.034
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.034
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.034
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.034
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.034
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.033
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.033
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.033
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.033
|
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
15 |
0.033
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.032
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.032
|
|
|
|
copper ion transmembrane transport
|
GO:0035434 |
5 |
0.032
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.032
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.031
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.031
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.031
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.031
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.031
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.030
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.030
|
|
|
|
regulation of humoral immune response
|
GO:0002920 |
22 |
0.030
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.030
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
|
positive regulation of t helper 1 cell cytokine production
|
GO:2000556 |
1 |
0.030
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.030
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.029
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.029
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.029
|
|
|
|
acute phase response
|
GO:0006953 |
10 |
0.029
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.029
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.029
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.028
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.028
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.028
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.028
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.028
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.028
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.028
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.028
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.028
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.028
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.028
|
|
|
|
arginine transport
|
GO:0015809 |
4 |
0.028
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.028
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.027
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.027
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.027
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.026
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.026
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.026
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.026
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.026
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class i
|
GO:0002474 |
9 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.025
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.025
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.025
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.025
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.025
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.025
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.025
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.024
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.024
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.024
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.024
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.024
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.024
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.024
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.024
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.024
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.024
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.023
|
|
|
|
protein n linked glycosylation
|
GO:0006487 |
12 |
0.023
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.023
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.023
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.023
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
positive regulation of immunoglobulin production in mucosal tissue
|
GO:2000558 |
1 |
0.023
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.023
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.023
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.023
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.023
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.023
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.022
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.022
|
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
14 |
0.022
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.022
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.022
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.022
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.022
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.022
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.022
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.022
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.022
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.022
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.022
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
|
positive regulation of t helper 2 cell cytokine production
|
GO:2000553 |
3 |
0.022
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.022
|
|
|
|
regulation of natural killer cell chemotaxis
|
GO:2000501 |
1 |
0.022
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.022
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.021
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.021
|
|
|
|
hemoglobin metabolic process
|
GO:0020027 |
13 |
0.021
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.021
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.021
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.021
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.021
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.021
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.021
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.021
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.021
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.020
|
Mouse |
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.020
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.020
|
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.020
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.020
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.020
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.020
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.020
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.020
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.020
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.020
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.020
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.020
|
|